Factors influencing RBC alloimmunization: Lessons learned from murine models

Transfusion Medicine and Hemotherapy

Volumn 41, Issue 6, 2014, Pages 406-419

  Ryder, Alex B ^a   Zimring, James C ^b,c   Hendrickson, Jeanne E ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PUGET SOUND BLOOD CENTER   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Alloimmunization; Murine models; RBC; Transfusion

Indexed keywords

BLOOD GROUP ANTIGEN; ERYTHROCYTE ANTIGEN; HEMOGLOBIN BETA CHAIN; HLA ANTIGEN; MICRORNA;

ALLOIMMUNIZATION; BACKCROSSING; BLOOD DONOR; BLOOD GROUP ABO SYSTEM; BLOOD STORAGE; CLEARANCE; DISEASE MODEL; ERYTHROCYTE; ERYTHROCYTE ALLOIMMUNIZATION; ERYTHROCYTE TRANSFUSION; GLOBIN GENE; GRAFT RECIPIENT; HEREDITY; HUMAN; IMMUNE STATUS; IMMUNOLOGICAL TOLERANCE; INFLAMMATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PATIENT SAFETY; PREGNANCY; REVIEW;

EID: 84918571737     PISSN: 16603796     EISSN: 16603818     Source Type: Journal    
DOI: 10.1159/000368995     Document Type: Review

References (124)

1. Bolton-Maggs PH, Cohen H: Serious hazards of transfusion (SHOT) haemovigilance and progress is improving transfusion safety. Br J Haematol 2013;163:303-314.
2. US Food and Drug Administration: Fatalities Reported to the FDA following Blood Collection and Transfusion: Annual Summary for Fiscal Year 2013. 2014. www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/ReportaProblem/Transfusion DonationFatalities/ucm391574.htm.
3. US Food and Drug Administration: Fatalities Reported to FDA Following Blood Collection and Transfusion. Annual Summary for Fiscal Year 2011. 2012. www.fda.gov/downloads/BiologicsBlood Vaccines/SafetyAvailability/ReportaProblem/TransfusionDonationFatalities/UCM300764.pdf.
4. Annual SHOT Report, 2012. 2012. www.shotuk.org/wp-content/uploads/2013/08/SHOT-Annual-Report-2012.pdf.
5. Moise KJ Jr, Argoti PS: Management and prevention of red cell alloimmunization in pregnancy: a systematic review. ObstetGynecol 2012;120:1132-1139.
6. Reid M, Lomas-Francis C: The Blood Group Antigen Facts Book, 2nd ed. Amsterdam, Elsevier, 2004.
7. Tormey CA, Stack G: Immunogenicity of blood group antigens: a mathematical model corrected for antibody evanescence with exclusion of naturally occurring and pregnancy-related antibodies. Blood 2009;114:4279-4282.
8. Tormey CA, Fisk J, Stack G: Red blood cell alloantibody frequency, specificity, and properties in a population of male military veterans. Transfusion 2008;48:2069-2076.
9. Schonewille H, Haak HL, van Zijl AM: RBC antibody persistence. Transfusion 2000;40:1127-1131.
10. Hendrickson JE, Tormey CA, Shaz BH: Red blood cell alloimmunization mitigation strategies. Transfus Med Rev 2014;28:137-144.
11. Redman M, Regan F, Contreras M: A prospective study of the incidence of red cell allo-immunisation following transfusion. Vox Sang 1996;71:216-220.
12. Schonewille H, van de Watering LM, Loomans DS, Brand A: Red blood cell alloantibodies after transfusion: factors influencing incidence and specificity. Transfusion 2006;46:250-256.
13. Higgins JM, Sloan SR: Stochastic modeling of human RBC alloimmunization: evidence for a distinct population of immunologic responders. Blood 2008;112:2546-2553.
14. Rosse WF, Gallagher D, Kinney TR, Castro O, Dosik H, Moohr J, Wang W, Levy PS: Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease. Blood 1990;76:1431-1437.
15. Chou ST, Jackson T, Vege S, Smith-Whitley K, Friedman DF, Westhoff CM: High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors. Blood 2013;122:1062-1071.
16. Picard C, Frassati C, Basire A, Buhler S, Galicher V, Ferrera V, Reviron D, Zappitelli JP, Bailly P, Chiaroni J: Positive association of DRB1 04 and DRB1 15 alleles with Fya immunization in a southern European population. Transfusion 2009;49:2412-2417.
17. Reviron D, Dettori I, Ferrera V, Legrand D, Touinssi M, Mercier P, de Micco P, Chiaroni J: HLA-DRB1 alleles and Jk (a) immunization. Transfusion 2005;45:956-959.
18. Schonewille H, Doxiadis, II, Levering WH, Roelen DL, Claas FH, Brand A: HLA-DRB1 associations in individuals with single and multiple clinically relevant red blood cell antibodies. Transfusion 2014;54:1971-1980.
19. Mollison's Blood Transfusion in Clinical Medicine, 11th ed. Oxford, Blackwell, 2005.
20. Bratosin D, Mazurier J, Tissier JP, Estaquier J, Huart JJ, Ameisen JC, Aminoff D, Montreuil J: Cellular and molecular mechanisms of senescent erythrocyte phagocytosis by macrophages. A review. Biochimie 1998;80:173-195.
21. Nagy ZA: A History of Modern Immunology: The Path toward Understanding. Amsterdam, Elsevier, 2014.
22. Hendrickson JE, Desmarets M, Deshpande SS, Chadwick TE, Hillyer CD, Roback JD, Zimring JC: Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells. Transfusion 2006;46:1526-1536.
23. Smith NH, Henry KL, Cadwell CM, Bennett A, Hendrickson JE, Frame T, Zimring JC: Generation of transgenic mice with antithetical KEL1 and KEL2 human blood group antigens on red blood cells. Transfusion 2012;52:2620-2630.
24. Radwanski K, Garraud O, Cognasse F, Hamzeh-Cognasse H, Payrat JM, Min K: The effects of red blood cell preparation method on in vitro markers of red blood cell aging and inflammatory response. Transfusion 2013;53:3128-3138.
25. Jy W, Ricci M, Shariatmadar S, Gomez-Marin O, Horstman LH, Ahn YS: Microparticles in stored red blood cells as potential mediators of transfusion complications. Transfusion 2011;51:886-893.
26. Danesh A, Inglis HC, Jackman RP, Wu S, Deng X, Muench MO, Heitman JW, Norris PJ: Exosomes from red blood cell units bind to monocytes and induce proinflammatory cytokines, boosting T-cell responses in vitro. Blood 2014;123:687-696.
27. Moroff G, Au Buchon JP, Pickard C, Whitley PH, Heaton WA, Holme S: Evaluation of the properties of components prepared and stored after holding of whole blood units for 8 and 24 hours at ambient temperature. Transfusion 2011;51(suppl 1):7s-14s.
28. Thibault L, Beausejour A, de Grandmont MJ, Lemieux R, Leblanc JF: Characterization of blood components prepared from whole-blood donations after a 24-hour hold with the platelet-rich plasma method. Transfusion 2006;46:1292-1299.
29. Glenister KM, Sparrow RL: Level of plateletderived cytokines in leukoreduced red blood cells is influenced by the processing method and type of leukoreduction filter. Transfusion 2010;50:185-189.
30. Hendrickson JE, Hillyer CD: Noninfectious serious hazards of transfusion. Anesth Analg 2009;108:759-769.
31. Blumberg N, Heal JM, Gettings KF: WBC reduction of RBC transfusions is associated with a decreased incidence of RBC alloimmunization. Transfusion 2003;43:945-952.
32. Singer ST, Wu V, Mignacca R, Kuypers FA, Morel P, Vichinsky EP: Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly Asian descent. Blood 2000;96:3369-3373.
33. Hussein E, Desooky N, Rihan A, Kamal A: Predictors of red cell alloimmunization in multitransfused Egyptian patients with beta-thalassemia. Arch Pathol Lab Med 2014;138:684-688.
34. van de Watering L, Hermans J, Witvliet M, Versteegh M, Brand A: HLA and RBC immunization after filtered and buffy coat-depleted blood transfusion in cardiac surgery: a randomized controlled trial. Transfusion 2003;43:765-771.
35. Schonewille H, Brand A: Alloimmunization to red blood cell antigens after universal leucodepletion. A regional multicentre retrospective study. Br J Haematol 2005;129:151-156.
36. Hendrickson JE, Hod EA, Spitalnik SL, Hillyer CD, Zimring JC: Leukoreduction decreases alloimmunogenicity of transfused murine RBCs. Blood 2009;114:646.
37. Desmarets M, Cadwell CM, Peterson KR, Neades R, Zimring JC: Minor histocompatibility antigens on transfused leukoreduced units of red blood cells induce bone marrow transplant rejection in a mouse model. Blood 2009;114:2315-2322.
38. Gilson CR, Kraus T, Hod EA, Hendrickson JE, Spitalnik SL, Hillyer CD, Shaz BH, Zimring JC: A novel mouse model of red blood cells storage and post-transfusion in vivo survival. Transfusion 2009;48:1456-1553.
39. Hendrickson JE, Hod EA, Spitalnik SL, Hillyer CD, Zimring JC: Storage of murine red blood cells enhances alloantibody responses to an erythroidspecific model antigen. Transfusion 2010;50:642-648.
40. Zimring JC, Smith N, Stowell SR, Johnsen JM, Bell LN, Francis RO, Hod EA, Hendrickson JE, Roback JD, Spitalnik SL: Strain-specific red blood cell storage, metabolism, and eicosanoid generation in a mouse model. Transfusion 2014;54:137-148.
41. Raval JS, Waters JH, Seltsam A, Scharberg EA, Richter E, Daly AR, Kameneva MV, Yazer MH: The use of the mechanical fragility test in evaluating sublethal RBC injury during storage. Vox Sang 2010;99:325-331.
42. Strauss RG, Cordle DG, Quijana J, Goeken NE: Comparing alloimmunization in preterm infants after transfusion of fresh unmodified versus stored leukocyte-reduced red blood cells. J Pediatr Hematol Oncol 1999;21:224-230.
43. Yazer MH, Triulzi DJ: Receipt of older RBCs does not predispose D-negative recipients to anti-D alloimmunization. Am J Clin Pathol 2010;134:443-447.
44. Zalpuri S, Schonewille H, Middelburg R, van de Watering L, de Vooght K, Zimring J, van der Bom JG, Zwaginga JJ: Effect of storage of red blood cells on alloimmunization. Transfusion 2013;53:2795-2800.
45. Veale MF, Healey G, Sparrow RL: Longer storage of red blood cells is associated with increased in vitro erythrophagocytosis. Vox Sang 2014;106:219-226.
46. Hendrickson JE, Hod EA, Hudson KE, Spitalnik SL, Zimring JC: Transfusion of fresh murine red blood cells reverses adverse effects of older stored red blood cells. Transfusion 2011;51:2695-2702.
47. Kannan M, Atreya C: Differential profiling of human red blood cells during storage for 52 selected microRNAs. Transfusion 2010;50:1581-1588.
48. Simon LM, Edelstein LC, Nagalla S, Woodley AB, Chen ES, Kong X, Ma L, Fortina P, Kunapuli S, Holinstat M, McKenzie SE, Dong JF, Shaw CA, Bray PF: Human platelet microRNA-mRNA networks associated with age and gender revealed by integrated plateletomics. Blood 2014;123:e37-45.
49. Kannan M, Mohan KV, Kulkarni S, Atreya C: Membrane array-based differential profiling of platelets during storage for 52 miRNAs associated with apoptosis. Transfusion 2009;49:1443-1450.
50. Nagalla S, Shaw C, Kong X, Kondkar AA, Edelstein LC, Ma L, Chen J, McKnight GS, Lopez JA, Yang L, Jin Y, Bray MS, Leal SM, Dong JF, Bray PF: Platelet microRNA-mRNA coexpression profiles correlate with platelet reactivity. Blood 2011;117:5189-5197.
51. Baumjohann D, Ansel KM: MicroRNA-mediated regulation of T helper cell differentiation and plasticity. Nat Rev Immunol 2013;13:666-678.
52. Land WG: Transfusion-related acute lung injury: the work of DAMPs. Transfus Med Hemother 2013;40:3-13.
53. Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, Brohi K, Itagaki K, Hauser CJ: Circulating mitochondrial damps cause inflammatory responses to injury. Nature 2010;464:104-107.
54. Lee YL, King MB, Gonzalez RP, Brevard SB, Frotan MA, Gillespie MN, Simmons JD: Blood transfusion products contain mitochondrial DNA damage-associated molecular patterns: a potential effector of transfusion-related acute lung injury. J Surg Res 2014;191:286-289.
55. Ing R, Segura M, Thawani N, Tam M, Stevenson MM: Interaction of mouse dendritic cells and malaria-infected erythrocytes: uptake, maturation, and antigen presentation. J Immunol 2006;176:441-450.
56. Hendrickson JE, Hod EA, Cadwell CM, Eisenbarth SC, Spiegel DA, Tormey CA, Spitalnik SL, Zimring JC: Rapid clearance of transfused murine red blood cells is associated with recipient cytokine storm and enhanced alloimmunogenicity. Transfusion 2011;51:2445-2454.
57. Seltsam A, Blasczyk R: Recombinant blood group proteins for use in antibody screening and identification tests. Curr Opin Hematol 2009;16:473-479.
58. Seltsam A, Wagner F, Lambert M, Bullock T, Thornton N, Scharberg EA, Grueger D, Schneeweiss C, Blasczyk R: Recombinant blood group proteins facilitate the detection of alloantibodies to high-prevalence antigens and reveal underlying antibodies: results of an international study. Transfusion 2014;54:1823-1830.
59. Brantley SG, Ramsey G: Red cell alloimmunization in multitransfused HLA-typed patients. Transfusion 1988;28:463-466.
60. Hudson KE, Lin E, Hendrickson JE, Lukacher AE, Zimring JC: Regulation of primary alloantibody response through antecedent exposure to a microbial T-cell epitope. Blood 2010;115:3989-3996.
61. Flegel WA: Molecular genetics and clinical applications for Rh. Transfus Apher Sci 2011;44:81-91.
62. Hendrickson J, Smith N, Girard-Pierce K, Tormey C, Henry K, Zimring J, Stowell S: A murine model of weak KEL: Similarities to weak Rh (D). Blood 2012;120:842.
63. Zimring JC, Cadwell CM, Chadwick TE, Spitalnik SL, Schirmer DA, Wu T, Parkos CA, Hillyer CD: Nonhemolytic antigen loss from red blood cells requires cooperative binding of multiple antibodies recognizing different epitopes. Blood 2007;110:2201-2208.
64. Zimring JC, Cadwell CM, Spitalnik SL: Antigen loss from antibody-coated red blood cells. Transfus Med Rev 2009;23:189-204.
65. Cadwell CM, Zimring JC: Cross-linking induces non-haemolytic antigen-loss from transfused red blood cells: a potential role for rheumatoid factor. Vox Sang 2008;95:159-162.
66. Hod EA, Cadwell CM, Liepkalns JS, Zimring JC, Sokol SA, Schirmer DA, Jhang J, Spitalnik SL: Cytokine storm in a mouse model of IgG-mediated hemolytic transfusion reactions. Blood 2008;112:891-894.
67. Hod EA, Zimring JC, Spitalnik SL: Lessons learned from mouse models of hemolytic transfusion reactions. Curr Opin Hematol 2008;15:601-605.
68. Liepkalns JS, Hod EA, Stowell SR, Cadwell CM, Spitalnik SL, Zimring JC: Biphasic clearance of incompatible red blood cells through a novel mechanism requiring neither complement nor Fcy receptors in a murine model. Transfusion 2012;52:2631-2645.
69. Liepkalns JS, Cadwell CM, Stowell SR, Hod EA, Spitalnik SL, Zimring JC: Resistance of a subset of red blood cells to clearance by antibodies in a mouse model of incompatible transfusion. Transfusion 2013;53:1319-1327.
70. Girard-Pierce KR, Stowell SR, Smith NH, Arthur CM, Sullivan HC, Hendrickson JE, Zimring JC: A novel role for C3 in antibody-induced red blood cell clearance and antigen modulation. Blood 2013;122:1793-1801.
71. Stowell SR, Henry KL, Smith NH, Hudson KE, Halverson GR, Park JC, Bennett AM, Girard-Pierce KR, Arthur CM, Bunting ST, Zimring JC, Hendrickson JE: Alloantibodies to a paternally derived RBC KEL antigen lead to hemolytic disease of the fetus/newborn in a murine model. Blood 2013;122:1494-1504.
72. Noizat-Pirenne F, Tournamille C, Bierling P, Roudot-Thoraval F, Le Pennec PY, Rouger P, Ansart-Pirenne H: Relative immunogenicity of Fya and K antigens in a Caucasian population, based on HLA class II restriction analysis. Transfusion 2006;46:1328-1333.
73. Stephen J, Cairns LS, Pickford WJ, Vickers MA, Urbaniak SJ, Barker RN: Identification, immunomodulatory activity, and immunogenicity of the major helper T-cell epitope on the K blood group antigen. Blood 2012;119:5563-5574.
74. Schonewille H, Doxiadis II, Levering WH, Roelen DL, Claas FH, Brand A: HLA-DRB1 associations in individuals with single and multiple clinically relevant red blood cell antibodies. Transfusion 2014;54:1971-1980.
75. Kacker S, Ness PM, Savage WJ, Frick KD, Shirey RS, King KE, Tobian AA: Economic evaluation of a hypothetical screening assay for alloimmunization risk among transfused patients with sickle cell disease. Transfusion 2014;54:2034-2044.
76. Schwartz RH: Immune response (IR) genes of the murine major histocompatibility complex. Adv Immunol 1986;38:31-201.
77. Kim BS, Jang YS: Constraints in antigen processing result in unresponsiveness to a T cell epitope of hen egg lysozyme in C57BL/6 mice. Eur J Immunol 1992;22:775-782.
78. Adorini L, Miller A, Sercarz EE: The fine specificity of regulatory T cells. I. Hen egg-white lysozymeinduced suppressor T cells in a genetically nonresponder mouse strain do not recognize a closely related immunogenic lysozyme. J Immunol 1979;122:871-877.
79. Tatari-Calderone Z, Minniti CP, Kratovil T, Stojakovic M, Vollmer A, Barjaktarevic I, Zhang E, Hoang A, Luban NL, Vukmanovic S: Rs660 polymorphism in Ro52 (SSA1; TRIM21) is a marker for age-dependent tolerance induction and efficiency of alloimmunization in sickle cell disease. Mol Immunol 2009;47:64-70.
80. Patel SR, Hendrickson JE, Smith NH, Cadwell CM, Ozato K, Morse HC 3rd, Yoshimi R, Zimring JC: Alloimmunization against RBC or PLT antigens is independent of TRIM21 expression in a murine model. Mol Immunol 2011;48:909-913.
81. Tatari-Calderone Z, Tamouza R, Le Bouder GP, Dewan R, Luban NL, Lasserre J, Maury J, Lionnet F, Krishnamoorthy R, Girot R, Vukmanovic S: The association of CD81 polymorphisms with alloimmunization in sickle cell disease. Clin Dev Immun 2013;2013:937846.
82. Hendrickson JE, Chadwick TE, Roback JD, Hillyer CD, Zimring JC: Inflammation enhances consumption and presentation of transfused RBC antigens by dendritic cells. Blood 2007;110:2736-2743.
83. Girard-Pierce K, Stowell SR, Smith NH, Henry KL, Zimring JC, Hendrickson JE: Marginal zone B cells mediate alloantibody formation to a clinically significant human RBC antigen in a murine model. Blood (ASH Annual Meeting Abstracts) 2012;120:843.
84. Chou ST, Liem RI, Thompson AA: Challenges of alloimmunization in patients with haemoglobinopathies. Br J Haematol 2012;159:394-404.
85. Chou ST: Transfusion therapy for sickle cell disease: a balancing act. Hematology Am Soc Hematol Educ Program 2013;2013:439-446.
86. Yazdanbakhsh K, Ware RE, Noizat-Pirenne F: Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management. Blood 2012;120:528-537.
87. Vichinsky EP, Earles A, Johnson RA, Hoag MS, Williams A, Lubin B: Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med 1990;322:1617-1621.
88. Aygun B, Padmanabhan S, Paley C, Chandrasekaran V: Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion 2002;42:37-43.
89. Fasano RM. Booth GS, Miles M. R., Du L, Koyama T, Meier ER, Luban NL: RBC alloimmunization is influenced by inflammatory status at the time of transfusion in patients with sickle cell disease. Blood 2013;122:40.
90. Bao W, Zhong H, Manwani D, Vasovic L, Uehlinger J, Lee MT, Sheth S, Shi P, Yazdanbakhsh K: Regulatory B-cell compartment in transfused alloimmunized and non-alloimmunized patients with sickle cell disease. Am J Hematol 2013;88:736-740.
91. Bao W, Zhong H, Li X, Lee MT, Schwartz J, Sheth S, Yazdanbakhsh K: Immune regulation in chronically transfused allo-antibody responder and nonresponder patients with sickle cell disease and beta-thalassemia major. Am J Hematol 2011;86:1001-1006.
92. Hendrickson JE, Hod EA, Perry JR, Ghosh S, Chappa P, Adisa O, Kean LS, Ofori-Acquah SF, Archer DR, Spitalnik SL, Zimring JC: Alloimmunization to transfused HOD red blood cells is not increased in mice with sickle cell disease. Transfusion 2012;52:231-240.
93. Smith NH, Henry KL, Cadwell CM, Bennett A, Hendrickson JE, Frame T, Zimring JC: Generation of transgenic mice with antithetical KEL1 and KEL2 human blood group antigens on red blood cells. Transfusion 2012;52:2620-2630.
94. Matzinger P: The danger model: a renewed sense of self. Science 2002;296:301-305.
95. Pradeu T, Cooper EL: The danger theory: 20 years later. Front Immunol 2012;3:287.
96. Smith NH, Hod EA, Spitalnik SL, Zimring JC, Hendrickson JE: Transfusion in the absence of inflammation induces antigen-specific tolerance to murine RBCs. Blood 2012;119:1566-1569.
97. Stowell SR, Girard-Pierce KR, Smith NH, Henry KL, Arthur CM, Zimring JC, Hendrickson JE: Transfusion of murine red blood cells expressing the human KEL glycoprotein induces clinically significant alloantibodies. Transfusion 2014;54:179-189.
98. Bao W, Yu J, Heck S, Yazdanbakhsh K: Regulatory T-cell status in red cell alloimmunized responder and nonresponder mice. Blood 2009;113:5624-5627.
99. Yu J, Heck S, Yazdanbakhsh K: Prevention of red cell alloimmunization by CD25 regulatory T cells in mouse models. Am J Hematol 2007;82:691-696.
100. Hendrickson JE, Hillyer CD, Zimring JC: Effects of inflammation on alloimmunization to 3 unique red blood cell specific antigens. Transfusion 2008;48:185A.
101. Hendrickson J, Roback, JD, Hillyer, CD, Easley, KA, Zimring, JC: Discrete toll like receptor agonists have differential effects on alloimmunization to red blood cells. Transfusion 2008:1869-1877.
102. Yazer MH, Triulzi DJ, Shaz B, Kraus T, Zimring JC: Does a febrile reaction to platelets predispose recipients to red blood cell alloimmunization? Transfusion 2009;49:1070-1075.
103. Papay P, Hackner K, Vogelsang H, Novacek G, Primas C, Reinisch W, Eser A, Mikulits A, Mayr WR, Kormoczi GF: High risk of transfusion-induced alloimmunization of patients with inflammatory bowel disease. Am J Med 2012;125:717 e711-718.
104. Vingert B, Tamagne M, Desmarets M, Pakdaman S, Elayeb R, Habibi A, Bernaudin F, Galacteros F, Bierling P, Noizat-Pirenne F, Cohen J: Partial dysfunction of TREG activation in sickle cell disease. Am J Hematol 2014;89:261-266.
105. Holz LE, McCaughan GW, Benseler V, Bertolino P, Bowen DG: Liver tolerance and the manipulation of immune outcomes. Inflamm Allergy Drug Targets 2008;7:6-18.
106. Hendrickson JE, Saakadze N, Cadwell CM, Upton JW, Mocarski ES, Hillyer CD, Zimring JC: The spleen plays a central role in primary humoral alloimmunization to transfused mHEL red blood cells. Transfusion 2009;49:1678-1684.
107. Benner R, van Oudenaren A: Antibody formation in mouse bone marrow. IV. The influence of splenectomy on the bone marrow plaque-forming cell response to sheep red blood cells. Cell Immunol 1975;19:167-182.
108. Hendrickson J, Stowell, SR, Smith, NH, Girard-Pierce, KR, Hudson KE, Zimring, JC: Transfused RBCs can be immunogenic in splenectomized mice: of inflammation, adjuvants, and anamnestic responses. Transfusion 2012;52(suppl):P1-030A.
109. Crary SE, Buchanan GR: Vascular complications after splenectomy for hematologic disorders. Blood 2009;114:2861-2868.
110. Schilling RF: Risks and benefits of splenectomy versus no splenectomy for hereditary spherocytosis - a personal view. Br J Haematol 2009;145:728-732.
111. Pahuja S, Pujani M, Gupta SK, Chandra J, Jain M: Alloimmunization and red cell autoimmunization in multitransfused thalassemics of Indian origin. Hematology 2010;15:174-177.
112. Ho HK, Ha SY, Lam CK, Chan GC, Lee TL, Chiang AK, Lau YL: Alloimmunization in Hong Kong southern Chinese transfusion-dependent thalassemia patient. Blood 2001;97:3999-4000.
113. McPherson ME, Anderson AR, Castillejo MI, Hillyer CD, Bray RA, Gebel HM, Josephson CD: HLA alloimmunization is associated with RBC antibodies in multiply transfused patients with sickle cell disease. Pediatr Blood Cancer 2010;54:552-558.
114. Thompson AA, Cunningham MJ, Singer ST, Neufeld EJ, Vichinsky E, Yamashita R, Giardina P, Kim HY, Trachtenberg F, Kwiatkowski JL: Red cell alloimmunization in a diverse population of transfused patients with thalassaemia. Br J Haematol 2011;153:121-128.
115. Vichinsky E, Neumayr L, Trimble S, Giardina PJ, Cohen AR, Coates T, Boudreaux J, Neufeld EJ, Kenney K, Grant A, Thompson AA: Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention (CME). Transfusion 2014;54:972-981; quiz 971.
116. Zalpuri S, Evers D, Zwaginga JJ, Schonewille H, de Vooght KM, le Cessie S, van der Bom JG: Immunosuppressants and alloimmunization against red blood cell transfusions. Transfusion 2014;54:1981-1987.
117. Stowell SR, Girard-Pierce KR, Arthur CM, Smith NH, Zimring JC, Hendrickson JE: KEL RBC transfusion induces IgG anti-KEL antibodies independent of CD4 T cells. Blood 2013;122:41.
118. Savalonis JM, Kalish RI, Cummings EA, Ryan RW, Aloisi R: Kell blood group activity of Gramnegative bacteria. Transfusion 1988;28:229-232.
119. Sasamoto Y, Kawano YI, Bouligny R, Wiggert B, Chader GJ, Gery I: Immunomodulation of experimental autoimmune uveoretinitis by intravenous injection of uveitogenic peptides. Invest Ophthalmol Vis Sci 1992;33:2641-2649.
120. Hilliard BA, Kamoun M, Ventura E, Rostami A: Mechanisms of suppression of experimental autoimmune encephalomyelitis by intravenous administration of myelin basic protein: ROLE of regulatory spleen cells. Exp Mol Pathol 2000;68:29-37.
121. Cremel M, Guerin N, Horand F, Banz A, Godfrin Y: Red blood cells as innovative antigen carrier to induce specific immune tolerance. Int J Pharm 2013;443:39-49.
122. Metzler B, Wraith DC: Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity. Int Immunol 1993;5:1159-1165.
123. Faria AM, Weiner HL: Oral tolerance: mechanisms and therapeutic applications. Adv Immunol 1999;73:153-264.
124. Hall AM, Cairns LS, Altmann DM, Barker RN, Urbaniak SJ: Immune responses and tolerance to the RhD blood group protein in HLA-transgenic mice. Blood 2005;105:2175-2179.